Literature DB >> 20144868

Semi-automated high-throughput fluorescent intercalator displacement-based discovery of cytotoxic DNA binding agents from a large compound library.

Lateca S Glass1, Aditi Bapat, Mark R Kelley, Millie M Georgiadis, Eric C Long.   

Abstract

High-throughput fluorescent intercalator displacement (HT-FID) was adapted to the semi-automated screening of a commercial compound library containing 60,000 molecules resulting in the discovery of cytotoxic DNA-targeted agents. Although commercial libraries are routinely screened in drug discovery efforts, the DNA binding potential of the compounds they contain has largely been overlooked. HT-FID led to the rapid identification of a number of compounds for which DNA binding properties were validated through demonstration of concentration-dependent DNA binding and increased thermal melting of A/T- or G/C-rich DNA sequences. Selected compounds were assayed further for cell proliferation inhibition in glioblastoma cells. Seven distinct compounds emerged from this screening procedure that represent structures unknown previously to be capable of targeting DNA leading to cell death. These agents may represent structures worthy of further modification to optimally explore their potential as cytotoxic anti-cancer agents. In addition, the general screening strategy described may find broader impact toward the rapid discovery of DNA targeted agents with biological activity. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20144868      PMCID: PMC2845320          DOI: 10.1016/j.bmcl.2010.01.033

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  A fluorescent intercalator displacement assay for establishing DNA binding selectivity and affinity.

Authors:  Winston C Tse; Dale L Boger
Journal:  Acc Chem Res       Date:  2004-01       Impact factor: 22.384

Review 3.  Natural products as sources of new drugs over the period 1981-2002.

Authors:  David J Newman; Gordon M Cragg; Kenneth M Snader
Journal:  J Nat Prod       Date:  2003-07       Impact factor: 4.050

4.  Defining the sequence-recognition profile of DNA-binding molecules.

Authors:  Christopher L Warren; Natasha C S Kratochvil; Karl E Hauschild; Shane Foister; Mary L Brezinski; Peter B Dervan; George N Phillips; Aseem Z Ansari
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

5.  Fluorescent intercalator displacement analyses of DNA binding by the peptide-derived natural products netropsin, actinomycin, and bleomycin.

Authors:  Mark A Lewis; Eric C Long
Journal:  Bioorg Med Chem       Date:  2006-01-24       Impact factor: 3.641

6.  The pyrrolobenzodiazepine dimer SJG-136 forms sequence-dependent intrastrand DNA cross-links and monoalkylated adducts in addition to interstrand cross-links.

Authors:  Khondaker M Rahman; Andrew S Thompson; Colin H James; Mathangi Narayanaswamy; David E Thurston
Journal:  J Am Chem Soc       Date:  2009-09-30       Impact factor: 15.419

7.  Dicationic near-linear biphenyl benzimidazole derivatives as DNA-targeted antiprotozoal agents.

Authors:  Mohamed A Ismail; Adalgisa Batista-Parra; Yi Miao; W David Wilson; Tanja Wenzler; Reto Brun; David W Boykin
Journal:  Bioorg Med Chem       Date:  2005-08-15       Impact factor: 3.641

Review 8.  Synthetic DNA minor groove-binding drugs.

Authors:  B S Reddy; S M Sondhi; J W Lown
Journal:  Pharmacol Ther       Date:  1999-10       Impact factor: 12.310

9.  Arresting cancer proliferation by small-molecule gene regulation.

Authors:  Liliane A Dickinson; Ryan Burnett; Christian Melander; Benjamin S Edelson; Paramjit S Arora; Peter B Dervan; Joel M Gottesfeld
Journal:  Chem Biol       Date:  2004-11

10.  CSI-FID: high throughput label-free detection of DNA binding molecules.

Authors:  Karl E Hauschild; James S Stover; Dale L Boger; Aseem Z Ansari
Journal:  Bioorg Med Chem Lett       Date:  2009-05-03       Impact factor: 2.823

View more
  12 in total

1.  Novel small-molecule inhibitor of apurinic/apyrimidinic endonuclease 1 blocks proliferation and reduces viability of glioblastoma cells.

Authors:  Aditi Bapat; Lateca S Glass; Meihua Luo; Melissa L Fishel; Eric C Long; Millie M Georgiadis; Mark R Kelley
Journal:  J Pharmacol Exp Ther       Date:  2010-05-26       Impact factor: 4.030

2.  A rapid fluorescent indicator displacement assay and principal component/cluster data analysis for determination of ligand-nucleic acid structural selectivity.

Authors:  Rafael Del Villar-Guerra; Robert D Gray; John O Trent; Jonathan B Chaires
Journal:  Nucleic Acids Res       Date:  2018-04-20       Impact factor: 16.971

3.  Identification of novel small molecule inhibitors of the XPA protein using in silico based screening.

Authors:  Tracy M Neher; Sarah C Shuck; Jing-Yuan Liu; Jian-Ting Zhang; John J Turchi
Journal:  ACS Chem Biol       Date:  2010-10-15       Impact factor: 5.100

4.  Genome-Edited Coincidence and PMP22-HiBiT Fusion Reporter Cell Lines Enable an Artifact-Suppressive Quantitative High-Throughput Screening Strategy for PMP22 Gene-Dosage Disorder Drug Discovery.

Authors:  Natalia J Martinez; John C Braisted; Patricia K Dranchak; John J Moran; Hunter Larson; Bryan Queme; Evgenia Pak; Amalia Dutra; Ganesha Rai; Ken Chih-Chien Cheng; John Svaren; James Inglese
Journal:  ACS Pharmacol Transl Sci       Date:  2021-06-10

5.  Melting thermodynamics of reversible DNA/ligand complexes at interfaces.

Authors:  Irina Belozerova; Rastislav Levicky
Journal:  J Am Chem Soc       Date:  2012-10-30       Impact factor: 15.419

6.  A fluorescence-based screen for ribosome binding antibiotics.

Authors:  Derrick Watkins; F A Norris; Sunil Kumar; Dev P Arya
Journal:  Anal Biochem       Date:  2012-12-19       Impact factor: 3.365

7.  Mechanism of Action and Initial, In Vitro SAR of an Inhibitor of the Shigella flexneri Virulence Regulator VirF.

Authors:  Anthony A Emanuele; George A Garcia
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

8.  Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells.

Authors:  Cinara O D'Sousa Costa; João H Araujo Neto; Ingrid R S Baliza; Rosane B Dias; Ludmila de F Valverde; Manuela T A Vidal; Caroline B S Sales; Clarissa A G Rocha; Diogo R M Moreira; Milena B P Soares; Alzir A Batista; Daniel P Bezerra
Journal:  Oncotarget       Date:  2017-11-01

9.  Xylopine Induces Oxidative Stress and Causes G2/M Phase Arrest, Triggering Caspase-Mediated Apoptosis by p53-Independent Pathway in HCT116 Cells.

Authors:  Luciano de Souza Santos; Valdenizia Rodrigues Silva; Leociley Rocha Alencar Menezes; Milena Botelho Pereira Soares; Emmanoel Vilaça Costa; Daniel Pereira Bezerra
Journal:  Oxid Med Cell Longev       Date:  2017-12-06       Impact factor: 6.543

10.  A ruthenium-based 5-fluorouracil complex with enhanced cytotoxicity and apoptosis induction action in HCT116 cells.

Authors:  Valdenizia Rodrigues Silva; Rodrigo S Corrêa; Luciano de Souza Santos; Milena Botelho Pereira Soares; Alzir Azevedo Batista; Daniel Pereira Bezerra
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.